Connor, Clark & Lunn Investment Management (CC&L)’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-45,575
| Closed | -$484K | – | 1533 |
|
|
2023
Q2 | $484K | Sell |
45,575
-6,360
| -12% | -$67.6K | ﹤0.01% | 990 |
|
|
2023
Q1 | $433K | Sell |
51,935
-4,190
| -7% | -$34.9K | ﹤0.01% | 924 |
|
|
2022
Q4 | $518K | Buy |
56,125
+15,887
| +39% | +$147K | ﹤0.01% | 854 |
|
|
2022
Q3 | $517K | Buy |
40,238
+23,077
| +134% | +$297K | ﹤0.01% | 810 |
|
|
2022
Q2 | $227K | Buy |
17,161
+5,204
| +44% | +$68.8K | ﹤0.01% | 910 |
|
|
2022
Q1 | $252K | Buy |
11,957
+2,562
| +27% | +$54K | ﹤0.01% | 909 |
|
|
2021
Q4 | $225K | Buy |
+9,395
| New | +$225K | ﹤0.01% | 954 |
|